Performance of the plasma Aß42/Aß40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort. (2021)
Attributed to:
UK Dementias Platform
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-021-00911-7
PubMed Identifier: 34686209
Publication URI: http://europepmc.org/abstract/MED/34686209
Type: Journal Article/Review
Volume: 13
Parent Publication: Alzheimer's research & therapy
Issue: 1